MODE OF ACTION: It is a systemic fungicide and has preventive and therapeutic effects. It is absorbed into the plant by the leaves. It is transported acropetally from leaves and translaminarly from roots.

INFORMATION ABOUT RESISTANCE: The plant protection product named EFDAL DONAZOL 250 EC is a fungicide classified as Group G1:3 according to its mechanism of action. Repeated applications of plant protection products with the same mechanism of action encourage the development of resistance. For this reason, in order to delay the development of resistance, do not exceed the total number of recommended applications of EFDAL DONAZOL 250 EC within the same production season. In cases where the application must be repeated, be careful to use plant protection products with different mechanisms of action (except Group G1:3).

COMPATIBILITY: It can be used by mixing with other plant protection products. However, it is recommended that the farmer conduct a physical pre-mixture trial based on his own means.

Pear - Black Spot: 1st Application: When flower buds swell (3-5 days before in places with branch spots), 2nd Application: During the white rosette period, 3rd Application: When 70-80% of the flower petals fall, 4th and Other applications: Should be applied considering the duration of effect of the plant protection product used.

Apple - Black Spot: 1st Application: When flower buds swell (3-5 days before in places with branch spots), 2nd Application: During the pink rosette bud period (When flowers are seen separately), 3rd Application: When 70-80% of the flower petals fall, 4th and Other applications: Should be applied considering the duration of effect of the plant protection product used in cases where climate conditions are suitable for the progression of the disease.

Sugar Beet - Leaf Spot Disease: The first application should be started when one Cercopora leaf spot is seen on 5% of the adult leaves of sugar beet. It should be continued at 15-20 day intervals.
Sugar Beet - Powdery Mildew: Application is started when disease symptoms are seen and continued at 20-day intervals as needed.